VeraSci
  • Who We Are
    • Leadership
    • Careers
    • Contact Us
  • Therapeutic Expertise
    • Dementia
    • Dermatology
    • Digital Therapeutics
    • Mood Disorders
    • Multiple Sclerosis
    • Parkinson’s Disease
    • Rare & Orphan Disorders
    • Schizophrenia
    • See All
  • What We Do
    • Consulting Services
    • Pathway eCOA & ePRO
    • Placebo Response Mitigation
    • Endpoints & Assessments
    • Remote Clinical Trials
    • Trial Services
    • Translation & Cultural Adaptation
  • Resources
    • News
    • Events
    • Blog
    • VeraSci Innovation Lab
  • Contact Us
    • Submit an RFP
  • Careers
Select Page

What Darwin Could Teach Us Today About Modern Vaccines and Related Health Policies

by Rebekkah Huss | Jan 10, 2022 | Blog

Dr. Luca Pani of WCG VeraSci co-authored an article discussing the connection between Darwinian evolution and the SARS-Cov-2 virus. Excerpt: “In short, Pasteur allowed us to imagine and build vaccines or drugs, while Darwin explained, with his theory of natural...

Remote, self-administered cognitive testing in healthy older adults with and without subjective cognitive decline using the tablet-based Brief Assessment of Cognition

by Rebekkah Huss | Dec 7, 2021 | Posters

WCG VeraSci is pleased to share results from a recent study examining the feasibility and reliability of remote, in-home self-administration of cognitive tests using the Pathway ePRO platform. Sixty-one older adults with and without subjective cognitive decline...

Study Supporting Effectiveness of the Placebo-Control Reminder Script (PCRS) Published in Neuropsychopharmacology

by Rebekkah Huss | Dec 8, 2020 | Blog, Press Releases

Neuropsychopharmacology recently published “Placebo Response Mitigation with a Participant-Focused Psychoeducational Procedure: A Randomized, Single-Blind, All Placebo Study in Major Depressive and Psychotic Disorders”. Dr. Bill Horan, Vice President Clinical Science...

Improving Data Quality for a Critical Multiple Sclerosis Endpoint

by Rebekkah Huss | Aug 4, 2020 | Blog

The Expanded Disability Status Scale (EDSS) is one of the most widely used endpoints in multiple sclerosis (MS) research and in clinical trials of investigational treatments for MS. The EDSS is an elaborate scoring system applied to a neurological examination that...

Neurostatus-EDSS for Pathway: Improved MS outcome assessment capabilities are now available on the VeraSci eCOA Platform

by Rebekkah Huss | Jul 14, 2020 | Press Releases

VeraSci, a leading provider of innovative scientific and technology services, announced today the expansion of their proprietary eCOA platform to fully integrate the Neurostatus-EDSS assessment and Neurostatus data clarification services for MS trials. VeraSci...
« Older Entries

Recent Posts

  • What Darwin Could Teach Us Today About Modern Vaccines and Related Health Policies
  • Remote, self-administered cognitive testing in healthy older adults with and without subjective cognitive decline using the tablet-based Brief Assessment of Cognition
  • Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Parkinson’s Disease

Archives

  • WCG VeraSci
  • 3211 Shannon Rd., Suite 300
  • Durham, NC 27707 USA
  • +1.919.401.4642
  • info@verasci.com
  • Who We Are
  • Leadership
  • Careers
  • Contact Us
  • Therapeutic Expertise
  • Dementia & Related Disorders
  • Dermatology
  • Mood Disorders
  • Multiple Sclerosis
  • Parkinson’s Disease & Related Disorders
  • Rare & Orphan Disorders
  • Schizophrenia
  • What We Do
  • Consulting Services
  • Pathway eCOA
  • Endpoints & Assessments
  • Remote Clinical Trials
  • Trial Services
  • Translation & Cultural Adaptation
  • Resources
  • News
  • Events
  • Blog
WCG Privacy Policy California Consumer Privacy Act
 
  • Linkedin
  • Twitter
  • RSS
  • Facebook
ISO 17100 certified ISO 17100 certified ISO 17100 certified
© 2021 Copyright VeraSci. All Rights Reserved.

Our website uses cookies to personalize content, save your preferences, and enhance your overall experience. If you click accept or continue to navigate our website, you agree to having those cookies set on your device. To learn more about adjusting your preferences please visit our WCG Privacy Policy.  Accept  Reject

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Uncategorized

Undefined cookies are those that are being analyzed and have not been classified into a category as yet.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Save & Accept